In line with the regulation of angiogenic markers observed in B cells in vitro upon co-culturing, the animal experiments confirmed the modulation of several angiogenic markers, including VEGF and IL8, upon co-injection with HMGB1-expressing tumor cells to enhance their proangiogenic profiles in the TME. The gene discussed is HMGB1; the disease is neoplasm.